Abdin, Alaa Din http://orcid.org/0000-0001-8190-7277
Hanifa, Omar
Aljundi, Wissam
Munteanu, Cristian
Seitz, Berthold
Suffo, Shady
Article History
Received: 13 August 2023
Revised: 29 September 2023
Accepted: 9 October 2023
First Online: 21 October 2023
Declarations
:
: This study was approved by the Ethics Committee of the Medical Association of Saarland, Germany (Nr. 123/20). All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki Declaration and its later amendments or comparable ethical standards. This article does not contain any studies with animals performed by any of the authors.
: For this type of retrospective study, formal consent is not required. However, all patients provided written informed consent before each IVI, as usual approach in our clinical practice.
: • <i>Financial interests:</i> Abdin AD has received speaker and consultant honoraria from Novartis and Bayer Company. Other authors declare they have no financial interests.• <i>Non-financial interests:</i> none.